Equitable Holdings’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-13,226
Closed -$346K – 1082
2023
Q2
$346K Sell
13,226
-6,205
-32% -$164K 0.01% 806
2023
Q1
$519K Buy
19,431
+3,825
+25% +$103K 0.01% 640
2022
Q4
$428K Buy
+15,606
New +$415K 0.01% 653

Other funds holding FTXH

Equitable Holdings's FTXH Position: Q3 2023 in Review

Equitable Holdings sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2023, closing a stake of 13,226 shares — an estimated $346K sold.

Equitable Holdings first reported a position in FTXH in Q4 2022 and held it in 3 quarters. The position peaked at $519K in Q1 2023. 19 funds tracked by Wall St. Rank hold FTXH as of Q3 2023.

  • Equitable Holdings reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q3 2023 after selling out during the quarter.
  • Equitable Holdings sold 13,226 First Trust Nasdaq Pharmaceuticals ETF shares in Q3 2023, an estimated $346K.
  • Equitable Holdings first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2022 and held it in 3 quarters.
  • Equitable Holdings's First Trust Nasdaq Pharmaceuticals ETF position peaked at $519K in Q1 2023.
  • 19 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2023.

Based on Equitable Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.